LIPA
Lysosomal acid lipase/cholesteryl ester hydrolase
Also known as: CESD, LAL, LICH_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P38571
- Gene
- LIPA
- Ensembl
- ENSG00000107798
- Chromosome
- 10
- Canonical length
- 399 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
This gene encodes lipase A, the lysosomal acid lipase (also known as cholesterol ester hydrolase). This enzyme functions in the lysosome to catalyze the hydrolysis of cholesteryl esters and triglycerides. Mutations in this gene can result in Wolman disease and cholesteryl ester storage disease. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jan 2014]
Canonical amino-acid sequenceUniProt
399 residues, UniProt reviewed canonical sequence.
>P38571|LIPA
1 MKMRFLGLVV CLVLWTLHSE GSGGKLTAVD PETNMNVSEI ISYWGFPSEE YLVETEDGYI
61 LCLNRIPHGR KNHSDKGPKP VVFLQHGLLA DSSNWVTNLA NSSLGFILAD AGFDVWMGNS
121 RGNTWSRKHK TLSVSQDEFW AFSYDEMAKY DLPASINFIL NKTGQEQVYY VGHSQGTTIG
181 FIAFSQIPEL AKRIKMFFAL GPVASVAFCT SPMAKLGRLP DHLIKDLFGD KEFLPQSAFL
241 KWLGTHVCTH VILKELCGNL CFLLCGFNER NLNMSRVDVY TTHSPAGTSV QNMLHWSQAV
301 KFQKFQAFDW GSSAKNYFHY NQSYPPTYNV KDMLVPTAVW SGGHDWLADV YDVNILLTQI
361 TNLVFHESIP EWEHLDFIWG LDAPWRLYNK IINLMRKYQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LIPA can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 375 nTPM
Expression across tissuesHPA
Tissue
- spleen: 375 nTPM
- small intestine: 214 nTPM
- liver: 205 nTPM
- lung: 160 nTPM
- duodenum: 158 nTPM
- lymph node: 149 nTPM
Single-cell type
- kupffer cells: 1,525 nCPM
- oligodendrocytes: 407 nCPM
- macrophages: 361 nCPM
- hofbauer cells: 319 nCPM
- enterocytes: 201 nCPM
- monocytes: 194 nCPM
Immune cell
- intermediate monocyte: 356 nTPM
- non-classical monocyte: 200 nTPM
- classical monocyte: 168 nTPM
- total PBMC: 160 nTPM
- myeloid DC: 124 nTPM
- MAIT T-cell: 41 nTPM
Brain region
- white matter: 200 nTPM
- medulla oblongata: 135 nTPM
- spinal cord: 101 nTPM
- pons: 99 nTPM
- cerebellum: 98 nTPM
- basal ganglia: 98 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about LIPA.
Disease | AllUniProt
Conditions LIPA is implicated in, by any mechanism.
- Cholesteryl ester storage disease (CESD) MIM:278000
- Wolman disease (WOLD) MIM:620151
Disease | GeneticClinVar
159 pathogenic / likely-pathogenic of 781 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Wolman disease
- Lysosomal acid lipase deficiency
- Cholesteryl ester storage disease
- Cardiovascular phenotype
- LIPA-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.23
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- acute inflammatory response
- adaptive thermogenesis
- adipose tissue development
- ATP biosynthetic process
- blood vessel endothelial cell differentiation
- bone marrow development
- cell morphogenesis
- cell proliferation in bone marrow
- cholesterol biosynthetic process
- cholesterol efflux
- cholesterol storage
- common myeloid progenitor cell proliferation
- defecation
- determination of adult lifespan
- endocytosis
- endosome to lysosome transport
- endothelial cell proliferation
- fat cell proliferation
- fatty acid metabolic process
- gene expression
- glucose metabolic process
- glycolytic process
- hematopoietic progenitor cell differentiation
- homeostasis of number of cells within a tissue
- lipid catabolic process
- lipid homeostasis
- lipid import into cell
- lipoprotein catabolic process
- liver morphogenesis
- low-density lipoprotein particle clearance
- lung development
- lysosome organization
- macrophage homeostasis
- mitochondrion organization
- mitotic cell cycle
- myeloid cell apoptotic process
- myeloid cell differentiation
- positive regulation of T cell receptor signaling pathway
- reactive oxygen species biosynthetic process
- regulation of mitochondrial membrane potential
- respiratory burst involved in inflammatory response
- response to cold
- response to dietary excess
- response to rapamycin
- response to vitamin A
- response to xenobiotic stimulus
- small GTPase-mediated signal transduction
- spleen development
- sterol metabolic process
- T cell apoptotic process
- T cell differentiation
- T cell proliferation
- tissue remodeling
- TOR signaling
- triglyceride metabolic process
- triglyceride-rich lipoprotein particle clearance
- vitamin A metabolic process
- multicellular organismal-level chemical homeostasis
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LIPA as an antibody target. Whether an autoantibody or antibody against LIPA could matter depends on whether native LIPA is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LIPA is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label LIPA as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...